0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8)

Order Now

  • Source

    Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

  • Clone

    1A2D9D8

  • Isotype

    Human IgG1 | Human Kappa

  • Conjugate

    Unconjugated

  • Antibody Type

    Recombinant Monoclonal

  • Reactivity

    Virus

  • Immunogen

    Recombinant HRSV (A) Fusion glycoprotein F0 derived from human 293 cells.

  • Specificity

    This product is a specific antibody specifically reacts with Postfusion glycoprotein F0/post-F protein (RSV).

  • Application
    ApplicationRecommended Usage
    ELISA0.1-500 ng/mL 
  • Purity

    >90% as determined by SDS-PAGE.

  • Purification

    Protein A purified/ Protein G purified

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Postfusion glycoprotein F0/post-F protein (RSV) SDS-PAGE

Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

Bioactivity-ELISA
 Postfusion glycoprotein F0/post-F protein (RSV) ELISA

Immobilized HRSV (A) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) (Cat. No. RSV-M662) with a linear range of 0.1-16 ng/mL. HRSV (A) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) is verified not recoginized by Monoclonal Anti-RSV-post-F0 Antibody, Human IgG1 (1A2D9D8) (Cat. No. RSV-M662) in low concentration (QC tested).

  • Background
    Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.
  • Clinical and Translational Updates

Comments (0)


ETA de productos en stock: 2 días laborables

Price(EUR) : €350.00

Price(EUR) : €2330.00

Promotion & Exhibitions



Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje